{
"info": {
"nct_id": "NCT00146601",
"official_title": "A Phase II Study of Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer",
"inclusion_criteria": "* Histologically or cytologically confirmed invasive breast cancer, with stage IV disease.\n* Tumors must be positive for estrogen receptors, progesterone receptors, or both.\n* Patients must be premenopausal.\n* Prior anti-estrogen therapy (with or without ovarian suppression)\n* Platelet count > 100,000/mm3\n* Age older than 18 years\n* ECOG performance status 0-2\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Hormonal treatment for metastatic disease\n* Pregnant or breast-feeding women\n* Postmenopausal\n* Concurrent hormonal therapy or chemotherapy\n* Prior fulvestrant therapy\n* More than three prior chemotherapy regimens for metastatic disease\n* Concurrent, long-term anticoagulation therapy\n* Severe, uncontrolled intercurrent illness\n* History of hypersensitivity to castor oil",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically confirmed invasive breast cancer, with stage IV disease.",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed invasive breast cancer",
"criterion": "invasive breast cancer",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "stage IV disease",
"criterion": "breast cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
}
]
},
{
"line": "* Tumors must be positive for estrogen receptors, progesterone receptors, or both.",
"criterions": [
{
"exact_snippets": "Tumors must be positive for estrogen receptors",
"criterion": "estrogen receptor status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "Tumors must be positive for ... progesterone receptors",
"criterion": "progesterone receptor status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* Patients must be premenopausal.",
"criterions": [
{
"exact_snippets": "Patients must be premenopausal.",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "premenopausal"
}
]
}
]
},
{
"line": "* Prior anti-estrogen therapy (with or without ovarian suppression)",
"criterions": [
{
"exact_snippets": "Prior anti-estrogen therapy",
"criterion": "anti-estrogen therapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
},
{
"exact_snippets": "with or without ovarian suppression",
"criterion": "ovarian suppression",
"requirements": [
{
"requirement_type": "concurrent treatment",
"expected_value": [
"with",
"without"
]
}
]
}
]
},
{
"line": "* Platelet count > 100,000/mm3",
"criterions": [
{
"exact_snippets": "Platelet count > 100,000/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 100000,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Age older than 18 years",
"criterions": [
{
"exact_snippets": "Age older than 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* ECOG performance status 0-2",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Hormonal treatment for metastatic disease",
"criterions": [
{
"exact_snippets": "Hormonal treatment for metastatic disease",
"criterion": "hormonal treatment",
"requirements": [
{
"requirement_type": "purpose",
"expected_value": "metastatic disease"
}
]
}
]
},
{
"line": "* Pregnant or breast-feeding women",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast-feeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Postmenopausal",
"criterions": [
{
"exact_snippets": "Postmenopausal",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "postmenopausal"
}
]
}
]
},
{
"line": "* Concurrent hormonal therapy or chemotherapy",
"criterions": [
{
"exact_snippets": "Concurrent hormonal therapy",
"criterion": "hormonal therapy",
"requirements": [
{
"requirement_type": "concurrency",
"expected_value": true
}
]
},
{
"exact_snippets": "Concurrent ... chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "concurrency",
"expected_value": true
}
]
}
]
},
{
"line": "* Prior fulvestrant therapy",
"criterions": [
{
"exact_snippets": "Prior fulvestrant therapy",
"criterion": "fulvestrant therapy",
"requirements": [
{
"requirement_type": "prior",
"expected_value": true
}
]
}
]
},
{
"line": "* More than three prior chemotherapy regimens for metastatic disease",
"criterions": [
{
"exact_snippets": "More than three prior chemotherapy regimens for metastatic disease",
"criterion": "prior chemotherapy regimens for metastatic disease",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Concurrent, long-term anticoagulation therapy",
"criterions": [
{
"exact_snippets": "Concurrent, long-term anticoagulation therapy",
"criterion": "anticoagulation therapy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "long-term"
},
{
"requirement_type": "concurrency",
"expected_value": true
}
]
}
]
},
{
"line": "* Severe, uncontrolled intercurrent illness",
"criterions": [
{
"exact_snippets": "Severe, uncontrolled intercurrent illness",
"criterion": "intercurrent illness",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": false
}
]
}
]
},
{
"line": "* History of hypersensitivity to castor oil",
"criterions": [
{
"exact_snippets": "History of hypersensitivity to castor oil",
"criterion": "hypersensitivity to castor oil",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}